Study of treatments for long COVID
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had COVID-19 at least 3 months ago and still have symptoms that fit the definition of long COVID.
- You belong to one of these symptom groups: heart-related symptoms (like chest pain or palpitations) with abnormal heart MRI; chronic cough with signs of airway inflammation; or severe fatigue with high inflammatory markers in your blood.
- You are not currently using steroids, strong immune-suppressing drugs, or certain other medications.
- You are willing to attend follow-up visits and complete surveys.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how long COVID affects the body and whether cardiopulmonary rehabilitation improves quality of life and physical function. It may help participants better understand their symptoms and see if a structured rehab program improves daily abilities.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
This trial tests a care program designed to help people who continue to have symptoms after recovering from COVID-19. It aims to prevent long-term health problems and improve well-being.
This trial studies how the lungs’ breathing (airflow) and blood flow may be off in people with long-COVID symptoms like tiredness, shortness of breath, or trouble exercising. It may help researchers understand what’s driving symptoms and what kinds of abnormalities could be targeted.
Hear when a new Post Acute Sequelae of SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.